Adsure Services hikes dividend as profits rise, prepares for potentially ‘game changing’ year ahead

Adsure Services has reported strong results for the year ended 31 March 2025, marking another successful year for the business assurance specialist.

The company demonstrated delivery on its strategic goals with significant improvements across key financial metrics whilst expanding its operational footprint.

Revenue climbed 7.7% to £10.0 million, more than doubling the previous year’s growth rate of 3.5%.

This acceleration reflects the company’s enhanced market position and successful client acquisition strategy across its core sectors. Adsure has alluded to their Aquis listing as a driving factor in securing new clients and leading talent.

Operating profit surged 61.4% to £0.9 million. Pre-tax profit jumped 74% to £0.8 million, whilst EBITDA rose to £1.18 million—a 35% increase that lifted margins to 11.8% from 9.4% the previous year.

These are very respectable results and helped support Adsure’s commitment to rewarding shareholders with progressive dividend increases.

The board has proposed a final dividend of 1.14 pence per share, representing a 15.2% increase. Cash balances remained steady at £1.1 million, providing financial stability for future growth initiatives.

“We have worked extremely hard to improve operational efficiencies across the business as revenue grows, and I’m thrilled that our efforts are bearing fruit, with EBITDA margin increasing to 11.8%,” said Vicky Davies, CFO of Adsure Services.

Operational progress

The company’s sector-led business development approach has yielded tangible results. New contracts were secured across health, housing, education, and local government sectors whilst staff utilisation targets were met by 83% of employees.

Adsure made strategic investments in technology, contracting K10 Vision to implement audit working paper software. The company’s proprietary TIAA Insight AI tool has reached testing stage, with early results showing outputs indistinguishable from human auditors. This digital transformation supports margin expansion and operational efficiency goals.

The group expanded into new markets, developing fraud prevention services for social housing and engaging with private sector rail freight operators. Entry into the private sector is particularly interesting.

Strategic focus

Adsure’s three-pillar strategy emphasises organic growth in core markets, accessing new service markets, and creating revolutionary business assurance technologies. The company benefits from its elevated profile following its Aquis listing, which has facilitated the recruitment of senior sector leaders.

Management addressed capacity constraints—the primary growth inhibitor—through restructured senior management and enhanced delivery models. Four lead directors now oversee the main business areas, whilst two senior directors manage operations and commercial activity.

The board expects continued strong trading performance in 2025/26, supported by a robust contract base and healthy new business pipeline. The company plans to refresh its five-year corporate plan, targeting growth in both volume and service scope.

“Our strong 2025 performance positions us well, but I’m focused on the significant opportunities ahead as a London-listed company,” said Kevin Limn, Chief Executive Officer of Adsure Services Plc.

“Having invested prudently in our technological capabilities, the coming year could prove to be game changing for Adsure Services as we pursue further operational efficiencies and margin expansion through the deployment of our proprietary AI tools.”

AIM movers: New orders for Kromek and delays for Aurrigo International

0

First Development Resources (LON: FDR), a minerals exploration company recently spun out from Power Metal Resources (LON: POW), has clawed back some of its losses over the past fortnight. London-based First Development Resources is focusing on the Wallal gold copper project in the Paterson province in Western Australia. On admission, £2.3m was raised at 6.67p/share and the company valued at £7.06m. The share price subsequently fell but it has rebounded 13.6% to 6.25p.

Falcon Oil & Gas (LON: FOG) says that the Shenandoah South 2H sidetrack at the Betaloo in Northern Territory achieved an average 90-day initial production flow rate of 6.7 million cubic feet per day. This suggests significant potential for the area. The drilling campaign continues. The share price increased 12.3% to 7.75p.

Detection technology developer Kromek (LON: KMK) has received a new contract award from the MoD to develop methods of enhancing detection of biological agents and orders for CBRN detection equipment worth £860,000 in total and most of this will be recognised in the first half of the current financial year. The share price rose 7% to 5.35p.

Metals One (LON: MET1) has invested £1m in the latest placing by Chile-focused lithium project developer CleanTech Lithium (LON: CTL). The placing raised a total of £4.3m at 5p/share. The cash was raised to finance the acquisition of an additional 30 licences in the Laguna Verde project for $600,000 and finance the development of the enlarged project. The additional licences should help to seek streamlined approval for the project. The Metals One share price improved 9.45% to 6.0195p, while the CleanTech Lithium share price slipped 18.5% to 5.5p.

FALLERS

Mobile Tornado (LON: MBT) is asking for shareholder approval to leave AIM. There is limited liquidity and one major shareholder in the mobile communications technology company, so the quotation is not worth the cost. The board intends to seek a buyer in the next two years and believe it would be easier as a private company. The plan is to leave on 9 September. The share price dived 53.6% to 0.65p, having been below 0.5p at one point this morning.

Versarien (LON: VRS) intends to accelerate the sales process of the remaining parts of the group, while it tries to secure additional finance for the group. If the disposals happen the proceeds are unlikely to cover liabilities and Versarien would be placed in administration. The share price slumped 34.2% to 0.0125p.

Autonomous vehicles developer Aurrigo International (LON: AURR) says weaker activity has hit revenues this year. Disruption from tariffs and delayed tenders have pushed revenues into next year. The tariffs are hampering demand for its supply of equipment to the automotive sector. Aurrigo has been awarded more than £1m of grant funding. Canaccord Genuity has slashed its 2025 forecast revenues from £12m to £7.5m and that means the expected loss is £3.9m. Net cash should be around £1m at the end of the year. The share price dipped 28.1% to 52.5p.

Pharmacogenetic testing company Genedrive (LON: GDR) expects revenues to double to £1m in the year to June 2025. There is also £600,000 of visible revenues for this year, and the growth is likely to be international. Genedrive is confident that there are significant long-term opportunities in the NHS, but this remains a challenging market. Cash is around £700,000 and ways of raising more money are being assessed. The share price fell 15.6% to 0.95p.

Rank Group: this Thursday’s Final’s will show just how under-rated the gaming group’s shares are

I now have an answer to my question of just eight months ago, when I last featured this gaming group’s shares. 
On Wednesday 16th October last year, I stated that I had been impressed by the number of recent sizeable ‘insider’ purchases at prices up to nearly 83p a share. 
I took the view that the shares of the Rank Group (LON;RNK), then 86p, were headed back over the 100p level – and I concluded my article by asking the question – “is this the time to take a gamble with The Rank Group?” 
The Answer 
Since then, the group’s shares have been up to 164.59p, that peak being re...

FTSE 100 gains as investors focus on rate cut hopes

The FTSE 100 was higher on Monday as mild optimism crept into equity markets with investors choosing to focus on the recent market repricing of the number of US interest rates set for this year.

London’s leading index was 0.3% higher at the time of writing.

Banks, including JPMorgan, are now predicting the Federal Reserve will cut rates in September, and interest rate markets are pricing on 50 bps of cuts by the end of the year.

This is in contrast to the pricing of just one interest rate cut this year before a poor US jobs report at the beginning of August.

“A pulse of positivity also sent stocks on Wall Street back towards record levels on Friday and US indices are set for a higher open as optimism continues to swirl,” said Susannah Streeter, head of money and markets, Hargreaves Lansdown.

“But there could be a swift change in sentiment. The focus will be on US inflation numbers out this week, a key determiner for the Fed’s interest rate decision next week. With Trump’s tariffs set to make swathes of goods more expensive for American consumers and businesses, investors will want to see to if higher prices are landing and what the outlook is likely to be ahead.”

FTSE 100 movers

The FTSE 100’s gain was broad, with the majority of constituents trading positively at the time of writing.

However, while most shares were higher, there were few risers adding more than 1%.

Pharma heavyweights AstraZeneca and GSK were higher by over 1% helping support the wider index. GSK announced that the FDA had accepted a gonorrhoea treatment for priority review, although this wasn’t majorly price sensitive.

Defence-related stocks were weaker, with BAE Systems and Babcock losing over 1% as defence-spending euphoria continued to diminish.

Melrose was the top FTSE 100 faller, dropping 1.8%, on nothing more than profit taking after the stock touched the highest level since the announcements of Trump’s Liberation Day tariffs last week.

Wishbone Gold strikes sulphide mineralisation at Red Setter project

Wishbone Gold shares surged on Monday after reporting drill results from its Red Setter Gold Dome Project in Western Australia.

Wishbone Gold shares have rallied in recent weeks in anticipation of a drill update, and investors have been rewarded with a very encouraging update. Shares were over 20% higher at the time of writing.

The first hole at the project has successfully intersected sulphide mineralisation at the predicted target depth.

Located just 15 kilometres southwest of Greatland Gold’s operating Telfer mine, the project has delivered early positive indicators. Drilling intersected zones of quartz-carbonate veining alongside sulphides, including chalcopyrite and pyrite, from approximately 520 metres depth.

The mineralisation appeared close to the 550-metre target depth identified by Mobile MT domal targeting, as interpreted by Expert Geophysics Limited in April. This proximity validates the geological model underpinning the exploration programme.

“The fracturing and evidence of sulphides from around 520 metres is encouraging,” the company stated. “We are seeing strong signs of mineralisation within the concept of a domal folded hinge structure, as predicted.”

Key geological indicators observed include changes in bedding of the host rock, extensive quartz-carbonate veining, and multiple sulphide zones throughout the hole. These features suggest the current drilling position sits peripheral to the main geological target.

The company now plans to collar a new hole 50-75 metres southwest of the current position. This adjustment aims to focus on what geologists believe represents the centre of the domal structure.

“Seeing the quartz-carbonate veining and sulphides at the expected target depth is highly encouraging at this early stage of the drill program,” said Ed Mead, Wishbone Gold WA director.

“Progress has been a little slower than originally expected due to the drill rig only drilling on day shift, however, processing of core on site and geological and structural logging is giving us real time information on the domal structural we are successfully targeting. This means that we are seeing the significant changes in the bedding of the host rock as we approached the 550m target depth, indicating folds associated with a dome. The zones of significant quartz-carbonate veining seen indicates the presence of hydrothermal fluids often associated with mineralisation. Chalcopyrite (copper sulphide), as blebs in the veining and within fractures, and some bleaching/alteration within the drill core is also seen as highly encouraging. Drilling continues.”

Versarien nears administration

Engineering materials group Versarien has appointed Leonard Curtis to conduct an accelerated sale of its remaining assets as part of a fire sale that is likely to leave shareholders with little value, if any.

Versarien has died a long, drawn-out death. But the end of the company is nearing, and shareholders could soon be put out of their misery.

After failing to gain any meaningful traction and racking up debts in the process, Versarien is seeking to sell off core assets to pay off liabilities.

The company is seeking offers by early September for Versarien plc and its stakes in Gnanomat SL and Total Carbide Limited.

The move follows cost-cutting measures including placing Versarien Graphene Limited into administration and liquidating two subsidiaries, extending the cash runway until end-August. Whilst dialogue continues with a strategic investor announced in March, the board warns there’s no certainty either this investment or asset sales will complete in time to avoid administration.

If asset sales proceed, proceeds are likely to fall short of group liabilities, potentially forcing the company to cease trading and enter administration. This would suspend AIM trading and leave shareholders with no expected return.

New AIM admission: First Development Resources focuses on Wallal project near Havieron

First Development Resources is a minerals exploration company spun out from AIM-quoted Power Metals Resources (LON: POW) and it is focused on three prospective projects in Western Australia and one in Northern Territory.  
The core project is at Wallal in Western Australia, and a drilling contractor has been appointed. Infrastructure is being prepared for drilling to commence as soon as possible at the copper gold project.
The cash raised in the flotation will fund the work programme and the overheads of the group. The first phase of Wallal project drilling should cost £315,000, and then ...

AIM weekly movers: Tasty completes fundraising

4

Canaccord Genuity discretionary clients have further reduced their stake in oil and gas company Westmount Energy (LON: WTE) from 6.87% to 0.001%. Management says there are no material changes in trading. The share price soared 129% to 1.95p.

At the end of week, there was significant trading in the shares of Trellus (LON: TRLS), which has developed a digital platform to manage complex chronic conditions. This is already the most shares traded in a single day since February. The share price jumped to 1.65p and ended the week up 69.2% to 1.1p.

SIMEC Atlantis Energy (LON: SAE) has reached financial close on the AW1 BESS project in South Wales. This is a 120MW generation project and construction has begun at Uskmouth. A global renewable energy partner is taking a 24.7% stake in the project. Zeus has increased the 2025 revenues forecast from £7.4m to £11.4m and the 2026 estimate from £7.5m to £12.5m. In each year the expected loss has been more than halved to around £3m. Net debt is expected to be £65.1m at the end of 2025 and rise to £99.9m one year later. The share price increased 63.2% to 3.1p.

Northern Standard has reduced its shareholding in Aptamer (LON: APTA) from 10.9% to 8.14%. Oberon Investments has raised its stake from 6.08% to 6.47%. This includes previous holdings of Crux and Lansdowne. The share price rose 56.9% to 0.565p.

FALLERS

Defence contractor RC Fornax (LON: RCFX) was heavily traded on Friday. There have not been as many trades in a single day since early April, not even when the profit warning was announced. The share price slumped 29.3% to 14.5p.

Restaurants operator Tasty (LON: TAST) raised £9.25m from a placing at 0.5p/share and a retail offer generated a further £870,00o. The Kaye family invested £500,000 in the retail offer. There will be £3m invested in the existing restaurants and a further £1m on operational efficiency. There will be £3.6m set aside to acquire restaurant brands. The share price lost some of last week’s gains and was down 27.3% to 0.6p.

Alex Duggan has been appointed interim chief executive of erectile dysfunction treatments developer Futura Medical (LON: FUM). Angela Hildreth is stepping down as finance director and has a six-month notice period. Eroxon sales remain unpredictable. Sales and marketing strategies are being assessed and there will be news when the interims are published in late September. The share price fell 25.2% to 9.35p.

Drug developer ImmuPharma (LON: IMM) reported a reduction in loss from £2.78m to £1.95m in the six months to June 2025. The underlying improvement is masked by a loss on a derivative asset. Studies have helped to strengthen the commercial viability of the P140 technology platform and discussions continue with potential partners. The share price declined 24% to 1.58p.

Anexo (LON: ANX) says its tender offer was heavily oversubscribed with 32.17 million shares tendered with excess tenders scaled back so that 20 million shares were purchased. At 60p/share, there was £20m returned to shareholders. There are 97.99 million shares in issue following the tender. Independent directors have recommended a 60p/share bid. The share price slipped 19.8% to 38.5p.

Aquis weekly movers: Smarter Web Company new convertible issue

Fintech Amazing AI (LON: AAI) chief executive Paul Mathieson bought 1.32 million shares at 0.75p each. He owns 57.4%. The share price rose a further 30% to 0.975p.  

Incanthera (LON: INC) says the Skin + CELL skincare range launches on 11 August. It will be available through www.skinandcell.com. The share price recovered 19% to 6.25p.

Igraine (LON: KING) has entered into a collaboration with Homerun Energy, the European subsidiary of Canada-based renewable energy and critical metals projects developer Homerun Resources Inc. The two companies will work together on UK alternative energy projects focused on electric vehicle charging and integrated battery storage. There is an initial pilot for a UK automotive manufacturer. The share price increased 18.2% 0.325p.

Vault Ventures (LON: VULT) holds 771.37 ETH, 2,200.32 SOL and four Bitcoin. The share price rebounded 3.45% to 0.015p.

EDX Medical (LON: EDX) is developing a pneumonia test for critically ill NHS patients. It is partnering with the Intensive Care Unit at Cambridge University Hospitals NHS Foundation Trust to develop a test that identifies the DNA or RNA of microbes that cause lung infection. Results should be available in 60 seconds. EDX Medical has licenced the IP for the test from the trust. A kit version will be developed to sell to other hospitals. The share price improved 2.44% to 10.5p.

Daniel Thwaites (LON: THW) director Ann Yerburgh has sold her entire holding of 3.67 million shares. The share price is 2.44% to 10.5p.

FALLERS

TruSpine Technologies (LON: TSP) has published a document to gain shareholder approval for a Bitcoin treasury policy and the new strategy to acquire intellectual property assets. The company also plans to change its name to TSP Advanced Technologies. The share price declined 20.8% to 0.95p.

Coinsilium (LON: COIN) has invested a further £5m andowns 181.9596 Bitcoin and the total value is £15.7m. The share price fell 19% to 5.875p.

Vaultz Capital (LON: V3TC) has taken its Bitcoin holding to 117.853279 and the total cost is £10m. The share price decreased 17.8% to 9.25p.

Yorkshire AI Labs has reduced its stake in IntellAM AI (LON: INT) from 18% to 15.4%. The share price dipped 10.7% to 125p.

Hot Rocks Investments (LON: HRIP) has bought an additional 3.125 million warrants in fully listed Hamak Gold (LON: HAMA) taking its holding to 15.625 million warrants exercisable at 0.8p each. The share price is 4% lower at 1.2p.

The Smarter Web Company (LON: SWC) raised £8.1m from a placing and subscription at 205p/share early in the week. It subsequently launched Smarter Convert, a capital raising structured as a convertible bond denominated in Bitcoin. Asset management firm TOBAM has subscribed $21m through three of its funds. The reference share price is 195p and the conversion price is a 5% premium to that price. After an initial six months, the company can force the conversion if the share price is 50% higher than the conversion price for ten trading days. If the bonds are not converted within 12 months then the holders will receive 98% of the bond value, although that figure depends on the movement in Bitcoin. The share price slipped 1.18% to 210p.

AIM movers: Fiinu publishes reversal document and Pennant International revenues delayed

9

There has been significant trading in the shares of Trellus (LON: TRLS), which has developed a digital platform to manage complex chronic conditions. This is already the most shares traded in a single day since February. The share price jumped 130.8% to 1.5p.

Shares in Fiinu (LON: BANK) have returned from suspension after the publication of the document for the reverse takeover of Poland-based foreign exchange brokerage Everfex. The initial payment of £8m will be satisfied by the issue of 80 million shares at 10p each and the rest will depend on performance and be payable via up to 20 million shares at 20p each. Everfex made a pre-tax profit of more than £600,000 for the four months to April 2025. The acquisition will broaden the range of activities of the company and provide opportunities for the Plugin Overdraft product. A subscription has generated £801,000 at 10p/share. The share price increased 14.3% to 11p.

Blue Star Capital (LON: BLU) investee company SatoshiPay, where it holds a 50% shareholding, has fully invested the £1m loan it provided. It paid for 72.03338 Ether and 9.26732 Coinbase Wrapped BTC digital assets. The later is backed 1:1 by native Bitcoin held by Coinbase. They are redeemable for the underlying asset. The share price is 8.06% higher at 16.75p.

Keras Resources (LON: KRS) says Utah-based Falcon Isle is planning a mining campaign for an additional 5,000 tons of rock phosphate to bolster inventories and satisfy forward orders. The Nayega manganese mine in northern Togo is starting to ramp up to full capacity. First shipments are anticipated in September. The share price rose 3.85% to 1.35p.

FALLERS

Premier African Minerals (LON: PREM) is implementing the changes identified for the plant test at the Zulu lithium and tantalum project. In the next week a decision will be made on whether to purchase the secondary spodumene float section. The original sorters still have to be replaced and the tantalum recovery circuit needs to be completed. The share price dipped 17.2% to 0.024p.

Software supplier Pennant International (LON: PEN) says that first half revenues are broadly in line from expectations, but revenues from the GenFly contract with the MoD have been delayed until next year because of new approval processes. Zeus has cut its 2025 forecast revenues by 14% to £10.7m and expects a loss of £1.7m. The 2026 pre-tax profit is maintained at £1.27m. The share price declined 10.7% to 25p.

Alex Duggan has been appointed interim chief executive of erectile dysfunction treatments developer Futura Medical (LON: FUM). Angela Hildreth is stepping down as finance director and has a six-month notice period. Eroxon sales remain unpredictable. Sales and marketing strategies are being assessed and there will be news when the interims are published in late September. The share price slipped 12.1% to 10.135p.

Metals explorer Rockfire Resources (LON: ROCK) says drilling will commence at the Molaoi zinc deposit in Greece will commence before the 15 September. There will be a 30-hole programme, and it should result in a maiden inferred germanium resource. A feasibility study will be started. The share price fell 4% to 0.12p.